TY - JOUR
T1 - Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire
T2 - Part 3. Determination of reliability
AU - Fukui, Mitsuru
AU - Chiba, Kazuhiro
AU - Kawakami, Mamoru
AU - Kikuchi, Shinichi
AU - Konno, Shinichi
AU - Miyamoto, Masabumi
AU - Seichi, Atsushi
AU - Shimamura, Tadashi
AU - Shirado, Osamu
AU - Taguchi, Toshihiko
AU - Takahashi, Kazuhisa
AU - Takeshita, Katsushi
AU - Tani, Toshikazu
AU - Toyama, Yoshiaki
AU - Yonenobu, Kazuo
AU - Wada, Eiji
AU - Tanaka, Takashi
AU - Hirota, Yoshio
PY - 2007/7
Y1 - 2007/7
N2 - Background. The manner of measuring the outcome of cervical myelopathy must be patient-oriented and have sufficient reliability and validity. The current Japanese Orthopaedic Association (JOA) scoring system for cervical myelopathy is widely used but has not met this requirement. The first- and second-round surveys established 24 items for inclusion on a new questionnaire for cervical myelopathy. The purpose of this study (the third-round survey A) was to confirm the reproducibility of patient responses to the selected questions. Methods. A total of 201 patients with cervical myelopathy and with no change of symptoms between the two interviews were included. Each patient was interviewed twice using the same questionnaire at an interval of 4 weeks. The reliability of the questionnaire was evaluated by determining the extension of the weighted kappa coefficients. Results. The weighted kappa coefficient for each item was >0.4, confirming that the test-retest reliability was acceptable. Conclusions. The newly developed JOA Cervical Myelopathy Evaluation Questionnaire was proven to have sufficient reliability.
AB - Background. The manner of measuring the outcome of cervical myelopathy must be patient-oriented and have sufficient reliability and validity. The current Japanese Orthopaedic Association (JOA) scoring system for cervical myelopathy is widely used but has not met this requirement. The first- and second-round surveys established 24 items for inclusion on a new questionnaire for cervical myelopathy. The purpose of this study (the third-round survey A) was to confirm the reproducibility of patient responses to the selected questions. Methods. A total of 201 patients with cervical myelopathy and with no change of symptoms between the two interviews were included. Each patient was interviewed twice using the same questionnaire at an interval of 4 weeks. The reliability of the questionnaire was evaluated by determining the extension of the weighted kappa coefficients. Results. The weighted kappa coefficient for each item was >0.4, confirming that the test-retest reliability was acceptable. Conclusions. The newly developed JOA Cervical Myelopathy Evaluation Questionnaire was proven to have sufficient reliability.
UR - http://www.scopus.com/inward/record.url?scp=34547432046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547432046&partnerID=8YFLogxK
U2 - 10.1007/s00776-007-1131-4
DO - 10.1007/s00776-007-1131-4
M3 - Article
C2 - 17657550
AN - SCOPUS:34547432046
SN - 0949-2658
VL - 12
SP - 321
EP - 326
JO - Journal of Orthopaedic Science
JF - Journal of Orthopaedic Science
IS - 4
ER -